Aquarius D13S319 Plus Deletion Probe, Model LPH068-A Product Usage: The D13S319 probe, labell...

FDA Device Recall #Z-1843-2019 — Class III — April 26, 2019

Recall Summary

Recall Number Z-1843-2019
Classification Class III — Low risk
Date Initiated April 26, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Cytocell Ltd.
Location Cambridge, N/A
Product Type Devices
Quantity 400

Product Description

Aquarius D13S319 Plus Deletion Probe, Model LPH068-A Product Usage: The D13S319 probe, labelled in red, covers a 156kb region including most of the DLEU2 gene, part of the DLEU1 gene and the D13S319 and D13S272 markers. The 13qter subtelomere specific probe, labelled in green, allows identification of chromosome 13 and acts as a control probe.

Reason for Recall

There is an error in the chromomap on the package insert.

Distribution Pattern

Worldwide Distribution - US Nationwide AL, CO, FL, HI, IA, IL, IN, KY, MA, MD, MI, MO, MS, NC, NJ, NY, TN, TX, UT, WA, and WI. The products were distributed to the following foreign countries: Canada.

Lot / Code Information

Lot Numbers: 058585, 061111, 061354, 062527

Other Recalls from Cytocell Ltd.

Recall # Classification Product Date
Z-2210-2023 Class II RET Distal Probe. Used in Fluorescence in situ ... May 24, 2023
Z-2209-2023 Class II RET Proximal Probe. Used in Fluorescence in sit... May 24, 2023
Z-0353-2023 Class II CytoCell BCL11B Proximal in FITC Spectrum-LDT f... Oct 27, 2022
Z-0341-2023 Class II CytoCell BCL11B Distal in Texas Red Spectrum- A... Oct 27, 2022
Z-0824-2022 Class III Cytocell 8 Square Template Slides (Glass)- micr... Feb 14, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.